Ping An Biomedical (PASW) Common Equity (2024 - 2025)

Ping An Biomedical's Common Equity history spans 2 years, with the latest figure at $6.3 million for Q3 2025.

  • For Q3 2025, Common Equity rose 730.24% year-over-year to $6.3 million; the TTM value through Sep 2025 reached $6.3 million, up 730.24%, while the annual FY2025 figure was $6.4 million, 733.63% up from the prior year.
  • Common Equity reached $6.3 million in Q3 2025 per PASW's latest filing, up from -$1.0 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $6.3 million in Q3 2025 to a low of -$1.0 million in Q3 2024.